Non-insulin-dependent diabetes mellitus and quality of life;Qualite de vie et diabete non-insulino-dependant

Diabetes and Metabolism

Volumn 23, Issue SUPPL. 4, 1997, Pages 44-48

  Tauber, J P ^a  

^a CHU RANGUEIL   (France)

Author keywords

Glipizide GITS; Non insulin dependent diabetes mellitus; Quality of life

Indexed keywords

GLIPIZIDE; OZIDIA; UNCLASSIFIED DRUG; ANTIDIABETIC AGENT;

CLINICAL TRIAL; DRUG RESEARCH; HOME MONITORING; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; QUALITY OF LIFE; REVIEW; STATISTICAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES; BLOOD GLUCOSE MONITORING; FRANCE; HYPERGLYCEMIA; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL;

BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 2; FRANCE; GLIPIZIDE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS; UNITED STATES;

EID: 0030831424     PISSN: 03381684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (12)

1. King H, Revers M. WHO Ad Hoc Diabetes Reporting Group Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. Diabetes Care, 1993, 16, 157-177.
2. Papoz L, Eschwege E. Epidémiologie du diabète non insulino-dépendant Traité de diabétologie, Ed. Pradel, Paris, 1990 : 329-334.
3. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H. Mortality from coronary heart disease and stroke in relation to degree of glycaemia : The White hall Study. Br Med J, 1987, 287, 867-870.
4. Moss JE, Klein R, Klein BE. The prevalence and incidence of lower extremity amputation in a diabetic population. Arch Intern Med, 1992, 152, 610-615.
5. Nathan DM, McKitrick CM, Larkin M, Schoffran R, Singer DE. Glycaemic control in diabetes mellitus : have change in therapy made a difference ? Am J of Med, 1996, 100, 157-163.
6. Kuusisto J, Mykkanen L, Pyorala K, Laasko M. NIDDM and its metabolic control predict coronary Heart Disease in ederly subjects. Diabetes, 1994, 43, 960-967.
7. Testa MA, Simonson DC. Beneficial Effects in Improved glycaemic control with Glipizide GITS on quality of life and symptom distress in NIDDM Diabetes, 1996, S2, 45, A285.
8. Consensus development panel. Consensus statement on self monitoring of blood glucose. Diabetes Care, 1987, 10, 95-99.
9. Charbonnel B, Boivineau C, Chopinet P, Daninos JM, Drouin P, Durain D, Guyon F, Passa Ph. Glycaemic self monitoring in the diabetic patient. Diabete & Metabolism, 1995, 21, 285-289.
10. American Diabetes Association : Nutritional recommandations and principles for people with diabetes mellitus. Diabetes Care, 1994, 17, 19-22.
11. Berelowitz M. Comparative efficacy of a once-daily controlled-release formulation of Glipizide and immediate-release Glizipide in patient with NIDDM. Diabetes Care, 1994, 17, 12, 1460-1464.
12. Dubost M. Cah Med, 1976, 6, 365, 70.